# Lessening Organ Dysfunction With VITamin C - COVID-19

> **NCT04401150** · PHASE3 · COMPLETED · sponsor: **Université de Sherbrooke** · enrollment: 392 (actual)

## Conditions studied

- Vitamin C
- COVID-19
- Hospitalized Patients

## Interventions

- **DRUG:** Vitamin C
- **DRUG:** Control

## Key facts

- **NCT ID:** NCT04401150
- **Lead sponsor:** Université de Sherbrooke
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-14
- **Primary completion:** 2022-07-15
- **Final completion:** 2022-12-06
- **Target enrollment:** 392 (ACTUAL)
- **Last updated:** 2023-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04401150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04401150, "Lessening Organ Dysfunction With VITamin C - COVID-19". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04401150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*